4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013513
VP Chief Financial Officer gave up 5,930 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamm John M. VP Chief Financial Officer | 2025-03-16 | Shares withheld for taxes | −5,930 | $5.46 | $32,378 | 20,073 | D |
| Derivatives | |||||||
| Hamm John M. VP Chief Financial Officer | 2025-03-17 | Grant or award · Options (right to buy) | +2,750 | $5.17 | $14,218 | 15,250 | D |
Loading xslF345X05/wk-form4_1742331988.xml…